Literature DB >> 15093543

Metadherin, a cell surface protein in breast tumors that mediates lung metastasis.

Darren M Brown1, Erkki Ruoslahti.   

Abstract

We used a phage expression library of cDNAs from metastatic breast carcinoma to identify protein domains that bind to the vasculature of the lung, a frequent site of breast cancer metastasis. We found that one protein domain selectively targeted phage as well as cells to the lung. This domain is part of the protein metadherin, shown by gene expression profiling to be overexpressed in metastatic breast cancer. Immunostaining revealed that metadherin is overexpressed in breast cancer tissue and breast tumor xenografts. Antibodies reactive to the lung-homing domain of metadherin and siRNA-mediated knockdown of metadherin expression in breast cancer cells inhibited experimental lung metastasis, indicating that tumor cell metadherin mediates localization at the metastatic site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15093543     DOI: 10.1016/s1535-6108(04)00079-0

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  165 in total

Review 1.  Treating metastatic cancer with nanotechnology.

Authors:  Avi Schroeder; Daniel A Heller; Monte M Winslow; James E Dahlman; George W Pratt; Robert Langer; Tyler Jacks; Daniel G Anderson
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

Review 2.  Biology and significance of circulating and disseminated tumour cells in colorectal cancer.

Authors:  Gunnar Steinert; Sebastian Schölch; Moritz Koch; Jürgen Weitz
Journal:  Langenbecks Arch Surg       Date:  2012-02-15       Impact factor: 3.445

Review 3.  Modeling metastasis in the mouse.

Authors:  Paula D Bos; Don X Nguyen; Joan Massagué
Journal:  Curr Opin Pharmacol       Date:  2010-07-01       Impact factor: 5.547

4.  Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.

Authors:  Gunjan Malik; Lynn M Knowles; Rajiv Dhir; Shuping Xu; Shuting Yang; Erkki Ruoslahti; Jan Pilch
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 5.  Tumor metastasis: molecular insights and evolving paradigms.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

6.  MiR-98 inhibits malignant progression via targeting MTDH in squamous cell carcinoma of the head and neck.

Authors:  Haolei Tan; Gangcai Zhu; Li She; Ming Wei; Yunyun Wang; Leiming Pi; Changhan Chen; Diekuo Zhang; Pingqing Tan; Jie Chen; Donghai Huang; Yongquan Tian; Yong Liu; Xin Zhang
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

Review 7.  AEG-1/MTDH/LYRIC in liver cancer.

Authors:  Devanand Sarkar
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 8.  Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes.

Authors:  Devanand Sarkar; Luni Emdad; Seok-Geun Lee; Byoung Kwon Yoo; Zao-Zhong Su; Paul B Fisher
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

9.  Serum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumors.

Authors:  Xi Chen; Ke Dong; Min Long; Fang Lin; Xi Wang; Junxia Wei; Jihong Ren; Huizhong Zhang
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

10.  Astrocyte elevated gene-1: a novel target for human glioma therapy.

Authors:  Luni Emdad; Devanand Sarkar; Seok-Geun Lee; Zhao Zhong Su; Byoung Kwon Yoo; Rupesh Dash; Adly Yacoub; Christine E Fuller; Khalid Shah; Paul Dent; Jeffrey N Bruce; Paul B Fisher
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.